Sign In
Buy PFE
$26.04
+0.345 (+1.34%)
At Close: Jun 05, 2026
Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock
10:05am, Friday, 18'th Oct 2024
Pfizer (PFE) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
October's 5 Dividend Growth Stocks With 5.10%+ Yields
09:59am, Friday, 18'th Oct 2024
Dividend growth stocks can offer a passive way to grow your cash flow over time that can be used to pay the bills during retirement. We screen for some attractive names to consider, looking at dividen
These 15 Stocks Are Among the Top Dividend Payers in the S&P 500
08:22am, Friday, 18'th Oct 2024
The Standard & Poor's 500 Index was created by credit agency Standard & Poor's in 1957.
3 No-Brainer Pharmaceutical Stocks to Buy With $500 Right Now
05:10am, Friday, 18'th Oct 2024
These stocks could deliver big over the long term.
Readers Identify 25 Ideal September Dividend Buys Out Of 39 Picks
01:39pm, Thursday, 17'th Oct 2024
Since May 2017, any dividend-paying stock mentioned by readers is included in my reader favorite listings, highlighting potential opportunities and risks. My stock lists aim to identify promising divi
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:50am, Thursday, 17'th Oct 2024
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Baby Boomers: 2 Dividend Stocks to Buy Under $30
09:37am, Wednesday, 16'th Oct 2024
Baby Boomers looking to put new money to work may wish to check out the broader basket of dividend stocks while interest rates are still relatively elevated.
Why I'm Considering Leaning Heavily Into Pfizer
06:00am, Wednesday, 16'th Oct 2024
Pfizer's high dividend yield and robust pipeline could offer significant returns for patient investors.
3 Top High-Yield Dividend Stocks to Buy in October 2024
11:38am, Tuesday, 15'th Oct 2024
As we move further into October, many investors may be looking to identify certain stocks with the potential to provide additional capital appreciation upside, but also some strong dividend income.
How to play biotech stocks: Johnson & Johnson, Pfizer
10:47am, Tuesday, 15'th Oct 2024
Goldman Sachs senior biotechnology analyst in global investment research Chris Shibutani joins Market Domination Hosts Julie Hyman and Josh Lipton to break down how to play biotech and pharmaceutical
Pfizer taps Vanguard veteran for board amid fight with Starboard
10:22am, Tuesday, 15'th Oct 2024
Pfizer appointed a former chief executive officer at Vanguard, the drug giant's biggest investor, to its board on Tuesday as it faces pressure from activist hedge fund Starboard Value.
Tim Buckley Elected to Pfizer's Board of Directors
06:45am, Tuesday, 15'th Oct 2024
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced the election of Mortimer (“Tim”) J. Buckley to its Board of Directors, effective immediately, following a lengthy and comprehensi
Pfizer Is Clashing With Its New Activist Investor. Will It Harm The Stock?
06:00am, Tuesday, 15'th Oct 2024
This investor's campaign is stoking some undesirable corporate intrigue.
2 Ultra-High-Yield Dividend Stocks With Total Return Potential of Up to 92% in 12 Months, According to Select Wall Street Analysts
04:41am, Tuesday, 15'th Oct 2024
Two supercharged income stocks -- sporting yields of 5.6% and 5.8% -- have the tools and intangibles needed to catapult higher.
Pfizer (PFE) Stock Drops Despite Market Gains: Important Facts to Note
06:51pm, Monday, 14'th Oct 2024
In the closing of the recent trading day, Pfizer (PFE) stood at $29.08, denoting a -0.27% change from the preceding trading day.
